Tests for Small Intestinal Bacterial Overgrowth (SIBO)

  1. ๐Ÿ“š Citations
  2. ๐Ÿฆ  Taxons (Bacteria) report by studies
  3. ๐Ÿฅฃ Candidates for improving (avoids and takes)
  4. ๐Ÿ”ฎ Bacteria Related Conditions
  5. es-xenogene is located in Spain and is expensive compared to others

Some 16s providers support download of FASTQ (raw data - BIG FILES). These can be processed thru other services (at the moment, Thryve and Biomesight offers free processing). The bacteria is determine by computer algorithms, which differs from lab to lab.

  1. Biomesight and BiomeSightRdp ships worldwide - including the US
  2. Thryve is now Ombre Labs but only ships to the US
  3. CosmosId is available thru NirvanaBiome
  4. Medivere is based in Germany
  5. American Gut
  6. Xenogene is both the most expensive and most detail for rare bacteria. They are based in Spain
  7. uBiome is no longer in business
The Percentage of significant bacteria each test reports on
Name Percentage
CosmosId 100%
es-xenogene 100%
SequentiaBiotech 100%
Thryve 100%
uBiome 100%
FASTQ processed thru both Thryve and BiomeSight 100%
BiomeSight 95.2%
Thorne 90.5%
Microba 81%
Medivere 76.2%
Diagnostic Solution GI-Map (cfu/gm) 71.4%
Genova Gi Effects (cfu/g) 71.4%
BiomeSightRdp 66.7%
Nordic Laboratories 61.9%
AmericanGut 61.9%
Gut Zoomer (vibrant-wellness) 61.9%
GanzimmunDiag 57.1%
NutriPATH 52.4%
Microba1 52.4%
GI EcologiX (Invivo) 33.3%
GI360 Stool (UK) 33.3%
GanzImmun Diagnostic A6 (cfu/gm) 33.3%
Biovis Microbiome Plus (cfu/g) 33.3%
InVitaLab (cfu/gm) 23.8%
Metagenomics Stool (De Meirleir) (16s Limited) 23.8%
DayTwo 19%
GanzImmun Diagnostics AG Befundbericht 19%
Genova Parasitology (cfu/g) 14.3%
Bioscreen (cfu/gm) 14.3%
Medivere: Darn Magen Diagnostik (16s Limited) 14.3%
Medivere: Gesundsheitscheck Darm (16s Limited) 14.3%
Smart Gut (ubiome 16s - Limited Taxonomy) 14.3%
Verisana (cfu/ml) aka (kbe/ml) 14.3%
Viome (Latest Reports Fail to provide ANY measurements) 9.5%
Kyber Kompakt (cfu/g) 9.5%
Medivere: Darm Mikrobiom Stuhltest (16s limited) 4.8%

All suggestions are computed solely on their predicted microbiome impact. Safety, side-effects etc must be evaluated by your medical professionals before starting. Some items suggests have significant risk of adverse consequences for some people.

Special thanks to David F Morrison and Geert Van Houcke for doing Quality Assurance. Special thanks to Oliver Luk, B.Sc. (Biology) from BiomeSight for spot checking the coding of data from the US National Library of Medicine

This is an Academic site. It generates theoretical models of what may benefit a specific microbiome results.

Copyright 2016-2023 Lassesen Consulting, LLC [2007], DBA, Microbiome Prescription. All rights served.
Permission to data scrap or reverse engineer is explicitly denied to all users. U.S. Code Title 18 PART I CHAPTER 47 ยงโ€ฏ1030, CETS No.185, CFAA
Use of data on this site is prohibited except under written license. There is no charge for individual personal use. Use for any commercial applications or research requires a written license.
Caveat emptor: Analysis and suggestions are based on modelling (and thus infererence) based on studies. The data sources are usually given for those that wish to consider alternative inferences. theories and models.

Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not Health Insurance Portability and Accountability Act of 1996 (HIPAA) compliant.

The awesome web hosting site that we use. Try it if you need to host (or unhappy with current provider)